Cardiovascular events in hospitalised patients with schizophrenia: a survival analysis

References

• Acil, A., Dogan, S., & Dogan, O. (2008). The effects of physical exercises to mental state and quality of life in patients with schizophrenia. Journal of Psychiatric and Mental Health Nursing, 15, 808–815. doi:10.1111/j.1365-2850.2008.01317.x
   PubMed Web of Science ®Google Scholar
• Allison, D. B., Newcomer, J. W., Dunn, A. L., Blumenthal, J. A., Fabricatore, A. N., Daumit, G. L., … Hibbeln, J. R. (2009). Obesity among those with mental disorders. A National Institute of Mental Health Meeting Report. American Journal of Preventive Medicine, 36, 341–350.
   Google Scholar
• Allison, D. B., Mentore, J. L., Heo, M., Chandler, L. P., Cappelleri, J. C., Infante, M. C., & Weiden, P. J. (1999). Antipsychotic-induced weight gain: a comprehensive research synthesis. American Journal of Psychiatry, 156, 1686–1696.
   PubMed Web of Science ®Google Scholar
• Association AP. (2000). Diagnostic and statistic manual of mental disorders. Washington, DC: American Psychiatric Association.
   Google Scholar
• Bernard, P., & Ninot, G. (2012). Benefits of exercise for people with schizophrenia: A systematic review. L'Encéphale, 38, 280–287. doi:10.1016/j.encep.2011.07.001
   PubMed Web of Science ®Google Scholar
• Birkenaes, A. B., Opjordsmoen, S., Brunborg, C., Engh, J. A., Jonsdottir, H., Ringen, P. A., … Friis, S. (2007). The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study. The Journal of Clinical Psychiatry, 68, 917–923. doi:10.4088/JCP.v68n0614
   PubMed Web of Science ®Google Scholar
• Brindle, P., Jonathan, E., Lampe, F., Walker, M., Whincup, P., Fahey, T., & Ebrahim, S. (2003). Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. Bmj, 327, 1267. doi:10.1136/bmj.327.7426.1267
   PubMed Web of Science ®Google Scholar
• Burbach, F. R. (1997). The efficacy of physical activity interventions within mental health services: anxiety and depressive disorders. Journal of Mental Health, 6, 543–566. doi:10.1080/09638239718428
   Google Scholar
• Bushe, C. J., Taylor, M., & Haukka, J. (2010). Mortality in schizophrenia: a measurable clinical endpoint. Journal of Psychopharmacology (Oxford, England), 24, 17–25. doi:10.1177/1359786810382468
   PubMed Web of Science ®Google Scholar
• Casey, D. E., Haupt, D. W., Newcomer, J. W., Henderson, D. C., Sernyak, M. J., Davidson, M., … Lebovitz, H. E. (2004). Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia. The Journal of Clinical Psychiatry, 65, 4–18.
   PubMed Web of Science ®Google Scholar
• Chalfoun, C., Karelis, A. D., Stip, E., & Abdel-Baki, A. (2016). Running for your life: a review of physical activity and cardiovascular disease risk reduction in individuals with schizophrenia. Journal of Sports Sciences, 34, 1500–1515. doi:10.1080/02640414.2015.1119875
   PubMed Web of Science ®Google Scholar
• Chia, Y. C., Lim, H. M., & Ching, S. M. (2014a). Does use of pooled cohort risk score overestimate the use of statin? A retrospective cohort study in a primary care setting. BMC Family Practice, 15, 172. doi:10.1186/s12875-014-0172-y
   PubMed Web of Science ®Google Scholar
• Chia, Y. C., Lim, H. M., & Ching, S. M. (2014b). Validation of the pooled cohort risk score in an Asian population–a retrospective cohort study. BMC Cardiovascular Disorders, 14, 163.
   PubMed Web of Science ®Google Scholar
• Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo Jr, J. L., … Wright, J. J. T. (2003). The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. Jama, 289, 2560–2571. doi:10.1001/jama.289.19.2560
   PubMed Web of Science ®Google Scholar
• Cohn, T., Prud'homme, D., Streiner, D., Kameh, H., & Remington, G. (2004). Characterizing coronary heart disease risk in chronic schizophrenia: high prevalence of the metabolic syndrome. The Canadian Journal of Psychiatry, 49, 753–760. doi:10.1177/070674370404901106
   PubMed Web of Science ®Google Scholar
• Correll, C. U., Solmi, M., Veronese, N., Bortolato, B., Rosson, S., Santonastaso, P., … Collantoni, E. (2017). Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large‐scale meta‐analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry, 16, 163–180. doi:10.1002/wps.20420
   PubMed Web of Science ®Google Scholar
• D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008). General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation, 117, 743–753. doi:10.1161/CIRCULATIONAHA.107.699579
   PubMed Web of Science ®Google Scholar
• D'Agostino, R. B., Sr Grundy, S., Sullivan, L. M., Wilson, P., & Group, C. R. P. (2001). Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. Jama, 286, 180–187. doi:10.1001/jama.286.2.180
   PubMed Web of Science ®Google Scholar
• Dawber, T. R., Meadors, G. F., & Moore, F. E. (1951). Epidemiological approaches to heart disease: the Framingham Study. American Journal of Public Health and the Nations Health, 41, 279–286. doi:10.2105/AJPH.41.3.279
   Web of Science ®Google Scholar
• De Hert, M., Dekker, J., Wood, D., Kahl, K., Holt, R., & Möller, H.-J. (2009). Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). European Psychiatry, 24, 412–424. doi:10.1016/j.eurpsy.2009.01.005
   PubMed Web of Science ®Google Scholar
• de Leon, J., & Diaz, F. J. (2005). A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophrenia Research, 76, 135–157. doi:10.1016/j.schres.2005.02.010
   PubMed Web of Science ®Google Scholar
• DeFilippis, A. P., Young, R., Carrubba, C. J., McEvoy, J. W., Budoff, M. J., Blumenthal, R. S., … Blaha, M. J. (2015). An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort. Annals of Internal Medicine, 162, 266–275. doi:10.7326/M14-1281
   PubMed Web of Science ®Google Scholar
• Dipasquale, S., Pariante, C. M., Dazzan, P., Aguglia, E., McGuire, P., & Mondelli, V. (2013). The dietary pattern of patients with schizophrenia: a systematic review. Journal of Psychiatric Research, 47, 197–207. doi:10.1016/j.jpsychires.2012.10.005
   PubMed Web of Science ®Google Scholar
• Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001). Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. Jama, 285, 2864–2870. doi:10.1001/jama.285.22.2864
   PubMed Web of Science ®Google Scholar
• Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., … O’Donnell, C. J. (2014). 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology, 63, 2935–2959. doi:10.1016/j.jacc.2013.11.005
   PubMed Web of Science ®Google Scholar
• Goff, D. C., Sullivan, L. M., McEvoy, J. P., Meyer, J. M., Nasrallah, H. A., Daumit, G. L., … Davis, S. (2005). A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophrenia Research, 80, 45–53. doi:10.1016/j.schres.2005.08.010
   PubMed Web of Science ®Google Scholar
• Gornik, H. L., & Beckman, J. A. (2005). Cardiology patient page. Peripheral arterial disease. Circulation, 111, e169–e172.
   PubMed Web of Science ®Google Scholar
• Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., … Stone, N. J. (2004). Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation, 110, 227–239. doi:10.1161/01.CIR.0000133317.49796.0E
   PubMed Web of Science ®Google Scholar
• Haddad, C., Hallit, S., Salameh, P., Bou-Assi, T., & Zoghbi, M. (2017). Coronary heart disease risk in patients with schizophrenia: a Lebanese cross-sectional study. Journal of Comorbidity, 7, 79 doi:10.15256/joc.2017.7.107
   PubMedGoogle Scholar
• Hartz, S. M., Pato, C. N., Medeiros, H., Cavazos-Rehg, P., Sobell, J. L., Knowles, J. A., … Pato, M. T. (2014). Comorbidity of severe psychotic disorders with measures of substance use. JAMA Psychiatry, 71, 248–254. doi:10.1001/jamapsychiatry.2013.3726
   PubMed Web of Science ®Google Scholar
• Heiskanen, T., Niskanen, L., Lyytikäinen, R., Saarinen, P. I., & Hintikka, J. (2003). Metabolic syndrome in patients with schizophrenia. J Clin Psychiatry, 64, 575–579. doi:10.4088/JCP.v64n0513
   PubMed Web of Science ®Google Scholar
• Hennekens, C. H., Hennekens, A. R., Hollar, D., & Casey, D. E. (2005). Schizophrenia and increased risks of cardiovascular disease. American Heart Journal, 150, 1115–1121. doi:10.1016/j.ahj.2005.02.007
   PubMed Web of Science ®Google Scholar
• Holley, J., Crone, D., Tyson, P., & Lovell, G. (2011). The effects of physical activity on psychological well‐being for those with schizophrenia: A systematic review. British Journal of Clinical Psychology, 50, 84–105. doi:10.1348/014466510X496220
   PubMed Web of Science ®Google Scholar
• Kannel, W. B., Feinleib, M., McNamara, P. M., Garrison, R. J., & Castelli, W. P. (1979). An investigation of coronary heart disease in families: the Framingham Offspring Study. American Journal of Epidemiology, 110, 281–290. doi:10.1093/oxfordjournals.aje.a112813
   PubMed Web of Science ®Google Scholar
• Kavousi, M., Leening, M. J., Nanchen, D., Greenland, P., Graham, I. M., Steyerberg, E. W., … Franco, O. H. (2014). Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort. Jama, 311, 1416–1423. doi:10.1001/jama.2014.2632
   PubMed Web of Science ®Google Scholar
• Kreyenbuhl, J., Dickerson, F. B., Medoff, D. R., Brown, C. H., Goldberg, R. W., Fang, L., … Dixon, L. B. (2006). Extent and management of cardiovascular risk factors in patients with type 2 diabetes and serious mental illness. The Journal of Nervous and Mental Disease, 194, 404 doi:10.1097/01.nmd.0000221177.51089.7d
   PubMed Web of Science ®Google Scholar
• Lahti, M., Tiihonen, J., Wildgust, H., Beary, M., Hodgson, R., Kajantie, E., … Eriksson, J. (2012). Cardiovascular morbidity, mortality and pharmacotherapy in patients with schizophrenia. Psychological Medicine, 42, 2275–2285. doi:10.1017/S0033291712000396
   PubMed Web of Science ®Google Scholar
• Mackin, P., Bishop, D., Watkinson, H., Gallagher, P., & Ferrier, I. N. (2007). Metabolic disease and cardiovascular risk in people treated with antipsychotics in the community. The British Journal of Psychiatry: The Journal of Mental Science, 191, 23–29. doi:10.1192/bjp.bp.106.031716
   PubMed Web of Science ®Google Scholar
• Meyer, J. M., & Koro, C. E. (2004). The effects of antipsychotic therapy on serum lipids: a comprehensive review. Schizophrenia Research, 70, 1–17. doi:10.1016/j.schres.2004.01.014
   PubMed Web of Science ®Google Scholar
• Mitchell, A. J., Vancampfort, D., Sweers, K., van Winkel, R., Yu, W., & De Hert, M. (2013). Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders-a systematic review and meta-analysis. Schizophrenia Bulletin, 39, 306–318. doi:10.1093/schbul/sbr148
   PubMed Web of Science ®Google Scholar
• Muntner, P., Colantonio, L. D., Cushman, M., Goff, D. C., Howard, G., Howard, V. J., … Safford, M. M. (2014). Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations. Jama, 311, 1406–1415. doi:10.1001/jama.2014.2630
   PubMed Web of Science ®Google Scholar
• Nasrallah, H. A., Meyer, J. M., Goff, D. C., McEvoy, J. P., Davis, S. M., Stroup, T. S., & Lieberman, J. A. (2006). Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. Schizophrenia Research, 86, 15–22. doi:10.1016/j.schres.2006.06.026
   PubMed Web of Science ®Google Scholar
• National cancer institute, division of cancer and epidemiology and genetics, Framingham Study - Exercise & Physical Activity Questionnaire, the Framingham Heart Study. Arch Intern Med 1979. Retrieved from: http://dceg.cancer.gov/tools/design/questionnaires/physical-activity/framingham-study-physical-activity [Last accessed Sep 25, 2017].
   Google Scholar
• Newcomer, J. W., & Haupt, D. W. (2006). The metabolic effects of antipsychotic medications. The. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 51, 480–491. doi:10.1177/070674370605100803
   PubMed Web of Science ®Google Scholar
• Osborn, D. P., Hardoon, S., Omar, R. Z., Holt, R. I., King, M., Larsen, J., … Walters, K. (2015). The PRIMROSE cardiovascular risk prediction models for people with severe mental illness: results from the PRIMROSE Research Programme: PRedIction and Management of cardiovascular Risk in peOple with SEvere mental illnesses. JAMA Psychiatry, 72, 143. doi:10.1001/jamapsychiatry.2014.2133
   PubMed Web of Science ®Google Scholar
• Robinson, D. G. (2016). Early mortality among people with schizophrenia. The American Journal of Psychiatry, 173, 554–555.
   PubMed Web of Science ®Google Scholar
• Singer, D. E., Albers, G. W., Dalen, J. E., Go, A. S., Halperin, J. L., & Manning, W. J. (2004). Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 126, 429S–456S. doi:10.1378/chest.126.3_suppl.429S
   PubMed Web of Science ®Google Scholar
• Vancampfort, D., Knapen, J., Probst, M., Scheewe, T., Remans, S., & De Hert, M. (2012). A systematic review of correlates of physical activity in patients with schizophrenia. Acta Psychiatrica Scandinavica, 125, 352–362. doi:10.1111/j.1600-0447.2011.01814.x
   PubMed Web of Science ®Google Scholar
• Wahlbeck, K., Westman, J., Nordentoft, M., Gissler, M., & Laursen, T. M. (2011). Outcomes of Nordic mental health systems: life expectancy of patients with mental disorders. The British Journal of Psychiatry: The Journal of Mental Science, 199, 453–458. doi:10.1192/bjp.bp.110.085100
   PubMed Web of Science ®Google Scholar
• Wilson, P. W., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998). Prediction of coronary heart disease using risk factor categories. Circulation, 97, 1837–1847. doi:10.1161/01.CIR.97.18.1837
   PubMed Web of Science ®Google Scholar
• Zoghbi, M., Haddad, C., Salameh, P., Haddad, G., & Hallit, S. (2017). Untreated dyslipidemia in lebanese patients with Schizophrenia. The Primary Care Companion for CNS Disorders, 19, 17m02099.
   Google Scholar